National Kidney Foundation Innovation Fund Invests in Revalia Bio to Advance Innovative Kidney Disease Therapeutics

NEW YORK, Oct. 17, 2024 /PRNewswire/ — The National Kidney Foundation (NKF) Innovation Fund is proud to announce its latest investment in Revalia Bio, an innovative health technology company focused on creating a new paradigm in how we develop and deliver personalized care for kidney…